Tele-spirometry in Primary Care - Randomized Clinical Trial Cluster: the Effectiveness of Telemedicine in Asthma

Tele-spirometry in Primary Care - Randomized Clinical Trial Cluster: the Effectiveness of Multifaceted Intervention in Symptoms Patients With Respiratory Illness.

Status

UNKNOWN

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT02901522

Acronym

RESPIRANET-A

Enrollment

120

Registered

2016-09-15

Start date

2015-05-31

Completion date

2017-12-31

Last updated

2017-01-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Asthma

Keywords

telemedicine, asthma control test, Primary Health care, spirometry

Brief summary

The purpose of this study is to determine the effectiveness of telemedicine multifaceted intervention in symptoms patients with asthma.

Detailed description

This study is a randomized clinical trial for patients with asthma from a primary care. The purpose is to determine the effectiveness of telemedicine (teleconsultation and telemonitoring) in control of asthma symptoms.

Interventions

OTHERtelemonitoring

Patients is evaluated by telemonitoring (phone call nurse - 45 and 90 days).

OTHERSpirometry (baseline)

Patients is evaluated by Asthma Control Test and spirometry at baseline and after 20 weeks.

OTHERSpirometry (20 - 22weeks)

Patients is evaluated by Asthma Control Test and spirometry at baseline and after 20 weeks.

OTHERTeleconsultation

The general practioner received phone call to asthma care.

Study design

Allocation

RANDOMIZED

Intervention model

SINGLE_GROUP

Primary purpose

TREATMENT

Masking

SINGLE (Investigator)

Eligibility

Sex/Gender

ALL

Age

12 Years to 100 Years

Healthy volunteers

Inclusion criteria

* individual with diagnosis asthma, Asthma Control Test \<20, spirometry from TelessaudeRS-Universidade Federal do Rio Grande do Sul (from randomization cluster)

Exclusion criteria

-low quality spirometries (inadequate)

Design outcomes

Primary

Measure	Time frame	Description
Symptoms control	20 to 22 weeks	Asthma Control Test (difference three points in the questionnaire ACT)

Secondary

Measure	Time frame	Description
Spirometry FVC	20 to 22 weeks	Spirometry parameters - FVC (forced vital capacity)
Spirometry FEV1	20 to 22 weeks	Spirometry parameters - FEV 1 (forced expiratory volume in one second)

Countries

Brazil

Contacts

Primary ContactMarcelo R. Gonçalves, PhD

marcelorog@gmail.com5191175156

Backup ContactCynthia G Molina-Bastos, MD

cyncarol@gmail.com5191322585

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026